Progressive hemifacial atrophy with linear scleroderma

Pediatric Dermatology

Volumn 22, Issue 5, 2005, Pages 436-439

  Dervis, Emine ^a   Dervis, Emel ^b  

^a Haseki General Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; DERMATOLOGICAL AGENT;

ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEMIFACIAL ATROPHY; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LINEAR SCLERODERMA; PATIENT REFERRAL; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN BIOPSY; SYMPTOM; LOCALIZED SCLERODERMA; TREATMENT OUTCOME;

CALCITRIOL; CHILD, PRESCHOOL; DERMATOLOGIC AGENTS; FACIAL HEMIATROPHY; FEMALE; HUMANS; SCLERODERMA, LOCALIZED; TREATMENT OUTCOME;

EID: 33644824143     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2005.00111.x     Document Type: Article

References (32)

1. Lewkonia RM, Lowry RB. Progressive hemifacial atrophy (Parry-Romberg syndrome) report with review of genetics and nosology. Am J Med Genet 1983 14 : 385 390.
2. Archambault L, Fromm NK. Progressive facial hemiatrophy. Arch Neurol Psychiatry 1932 7 : 529 584.
3. Hickman JW, Shiels WS. Progressive facial hemiatrophy. Arch Intern Med 1964 113 : 716 718.
4. Roddi R, Riggio E, Gilber PM, et al. Progressive hemifacial atrophy in a patient with lupus erythematosus. Plast Reconstr Surg 1994 93 : 1067 1072.
5. Menni S, Marzano AV, Passoni E. Neurologic abnormalities in two patients with facial hemiatrophy and sclerosis coexisting with morphea. Pediatr Dermatol 1997 14 : 113 116.
6. Johnson RV, Kennedy WR. Progressive facial hemiatrophy (Parry-Romberg syndrome). Contralateral extraocular muscle impairment. Am J Ophtalmol 1969 67 : 561 564.
7. Schwartz RA, Tedesco AS, Stern LZ, et al. Myopathy associated with sclerodermal facial hemiatrophy. Arch Neurol 1981 38 : 592 594.
8. Dupont S, Catala M, Hasboun MD, et al. Progressive facial hemiatrophy and epilepsy: a common underlying dysgenetic mechanism. Neurology 1997 48 : 1013 1018.
9. Lakhani PK, David TJ. Progressive hemifacial atrophy scleroderma and ipsilateral limb wasting (Parry-Romberg syndrome). J R Soc Med 1984 77 : 138 139.
10. Braun-Falco O, Plewig G, Wolff HH, et al. Diseases of connective tissue. In : Braun-Falco O, Plewig G, Wolff HH, et al, eds. Dermatology, 2nd edn. New York : Springer-Verlag Berlin Heidilberg, 1996 : 773 774.
11. McKusick VA. Mendelian inheritance. In: McKusick VA, Francomano CA, Antonarakis SE, eds. Man: catalogs of autosomal dominant, autosomal recessive and X-linked phenotypes, 11th edn. Baltimore : John Hopkins University Press, 1994 : 621.
12. Pensler JM, Murphy GF, Muliken JB. Clinical and ultrastructural studies of Romberg's hemifacial atrophy. Plast Reconstr Surg 1990 85 : 669 676.
13. Henta T, Itoh Y, Tajima S, et al. Axonal degeneration of peripheral facial nerve in a patient with progressive atrophy. Plast Reconstr Surg 1999 103 : 1700 1702.
14. Blaszczyk M, Janninger CK, Jablonska S. Childhood scleroderma and its peculiarities. Cutis 1996 58 : 141 152.
15. Tuffanelli DL. Localized scleroderma. Semin Cutan Med Surg 1998 17 : 27 33.
16. Emery H. Pediatric scleroderma. Semin Cutan Med Surg 1998 17 : 41 47.
17. Lehman TJA. The Parry-Romberg syndrome of progressive facial hemiatrophy and linear scleroderma en coup de sabre: Mistaken diagnosis or overlapping conditions? J Rheumatol 1992 19 : 844 845.
18. Jablonska S, Blaszczyk M. Scleroderma-like disorders. Semin Cutan Med Surg 1998 17 : 65 76.
19. Blaszczyk M, Krysicka CJ, Jablonska S. Primary atrophic profound linear scleroderma. Dermatology 2000 200 : 63 66.
20. Wartenburg R. Progressive facial hemiatrophy. Arch Neurol Psychiatr 1945 54 : 75 96.
21. Gambichler T, Kreuter A, Hoffmann K, et al. Bilateral linear scleroderma "en coup de sabre" associated with facial atrophy and neurological complications. BMC Dermatol 2001 1 : 9.
22. Suttorb-Schulten MS, Koornnef L. Linear scleroderma associated with ptosis and motility disorders. Br J Ophthalmol 1990 74 : 694 695.
23. Rushton M. Asymmetry of tooth size in congenital hypoplasia of one side of body. Br Dent J 1953 95 : 309 311.
24. Foster TD, Fairburn EA. Dental involvement in scleroderma. Br Dent J 1968 124 : 353 356.
25. Foster TD. The effects of hemifacial atrophy on dental growth. Br Dent J 1979 146 : 148 150.
26. Mazzeo N, Fisher BS, Mayer MH. Progressive hemifacial atrophy (Parry-Romberg syndrome). Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995 79 : 30 35.
27. Glass D. Hemifacial atrophy. Br J Oral Surg 1964 1 : 194 199.
28. Hunzelmann N, Scharffetter Kochanek K, Hager K, et al. Management of localized scleroderma. Semin Cutan Med Surg 1998 17 : 34 40.
29. Humbert PG, Dupond JL, Rocheford A, et al. Localized scleroderma: response to 1.25-dihydroxyvitamin D3. Clin Exp Dermatol 1990 15 : 396 398.
30. Humbert PG, Dupond JL, Agache P, et al. Treatment of linear scleroderma with oral 1.25-dihydroxyvitamin D3: evaluation of skin involvement using noninvasive techniques. Acta Derm Venereol (Stockh) 1993 73 : 449 451.
31. Hulshof MM, Pavel S, Breedveld FC, et al. Oral calcitriol as a new therapeutic modality for generalized morphea. Arch Dermatol 1994 130 : 129 1293.
32. Elst EF, van Suijlekom-Smit LWA, Oranje AP. Treatment of linear scleroderma with oral 1.25-dihydroxyvitamin D3 (calcitrol) in seven children. Pediatr Dermatol 1999 16 : 53 58.